DAWN BRIDGES-JONES: Open Payments
NPI 1891107322 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,043 in 9 payments from 7 companies in 2025. Trend: 2023 $815 · 2024 $1,319 · 2025 $1,043
Food & beverage: $1,043
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $231 |
| Alkermes, Inc. | 2 | $197 |
| Janssen Pharmaceuticals, Inc | 1 | $126 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $124 |
| ABBVIE INC. | 1 | $124 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
Products named: SPRAVATO, CAPLYTA, CREON, UZEDY, REXULTI, COBENFY, AUSTEDO XR, LYBALVI.
Industry payments across AZ — which companies pay providers there.
